BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 26871274)

  • 1. Differential contribution of orexin receptors within the ventral tegmental area to modulation of persistent inflammatory pain.
    Ezzatpanah S; Babapour V; Haghparast A
    Eur J Pain; 2016 Aug; 20(7):1090-101. PubMed ID: 26871274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray.
    Lee HJ; Chang LY; Ho YC; Teng SF; Hwang LL; Mackie K; Chiou LC
    Neuropharmacology; 2016 Jun; 105():577-586. PubMed ID: 26907809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-accumbal Orexin-1 Receptors are Involved in Antinociception Induced by Stimulation of the Lateral Hypothalamus in the Formalin Test as an Animal Model of Persistent Inflammatory Pain.
    Jahangirvand M; Yazdi F; Moradi M; Haghparast A
    Iran J Pharm Res; 2016; 15(4):851-859. PubMed ID: 28243282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of spinal orexin-1 receptors in posterior hypothalamic modulation of neuropathic pain.
    Jeong Y; Holden JE
    Neuroscience; 2009 Apr; 159(4):1414-21. PubMed ID: 19409203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin-A attenuated motion sickness through modulating neural activity in hypothalamus nuclei.
    Pan L; Xiao S; Xu Z; Li W; Zhao L; Zhang L; Qi R; Wang J; Cai Y
    Br J Pharmacol; 2024 May; 181(9):1474-1493. PubMed ID: 38129941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of VTA dopamine inputs to LH upregulates orexin neuronal activity in a DRD2-dependent manner.
    Harada M; Capdevila LS; Wilhelm M; Burdakov D; Patriarchi T
    Elife; 2024 Apr; 12():. PubMed ID: 38567902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia.
    Perez SM; Lodge DJ
    Int J Neuropsychopharmacol; 2021 Apr; 24(4):344-353. PubMed ID: 33587746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An NK1 receptor antagonist microinjected into the periaqueductal gray blocks lateral hypothalamic-induced antinociception in rats.
    Holden JE; Pizzi JA; Jeong Y
    Neurosci Lett; 2009 Apr; 453(2):115-9. PubMed ID: 19356605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin-1 Receptor Antagonist SB-334867 Enhances Formalin-Induced Nociceptive Behaviors in Adult Male Rats.
    Kourosh-Arami M; Komaki A; Gholami M
    Avicenna J Med Biotechnol; 2024; 16(1):29-33. PubMed ID: 38605740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of orexin receptor 1 antagonist into the rostral ventromedial medulla increased swim stress-induced antinociception in rat.
    Soliemani N; Moslem A; Shamsizadeh A; Azhdari-Zarmehri H
    Iran J Basic Med Sci; 2016 May; 19(5):542-9. PubMed ID: 27403261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis.
    Elam HB; Perez SM; Donegan JJ; Lodge DJ
    Transl Psychiatry; 2021 Feb; 11(1):114. PubMed ID: 33558469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral hypothalamus orexinergic projection to the medial prefrontal cortex modulates chronic stress-induced anhedonia but not anxiety and despair.
    Liu D; Zheng X; Hui Y; Xu Y; Du J; Du Z; Che Y; Wu F; Yu G; Zhang J; Gong X; Guo G
    Transl Psychiatry; 2024 Mar; 14(1):149. PubMed ID: 38493173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of orexin-2 receptors in the nucleus accumbens in antinociception induced by carbachol stimulation of the lateral hypothalamus in formalin test.
    Yazdi F; Jahangirvand M; Ezzatpanah S; Haghparast A
    Behav Pharmacol; 2016 Aug; 27(5):431-8. PubMed ID: 26871404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.
    Yin J; Babaoglu K; Brautigam CA; Clark L; Shao Z; Scheuermann TH; Harrell CM; Gotter AL; Roecker AJ; Winrow CJ; Renger JJ; Coleman PJ; Rosenbaum DM
    Nat Struct Mol Biol; 2016 Apr; 23(4):293-9. PubMed ID: 26950369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disinhibition of Mesolimbic Dopamine Circuit by the Lateral Hypothalamus Regulates Pain Sensation.
    Ma Y; Zhao W; Chen D; Zhou D; Gao Y; Bian Y; Xu Y; Xia SH; Fang T; Yang JX; Song L; Liu H; Ding HL; Zhang H; Cao JL
    J Neurosci; 2023 Jun; 43(24):4525-4540. PubMed ID: 37188517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Orexinergic System Within the Ventral Tegmental Area in the Development of Sensitization to Morphine Induced by Lateral Hypothalamus Stimulation.
    Haghparast A; Rashvand M
    Basic Clin Neurosci; 2022; 13(1):97-106. PubMed ID: 36589022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroacupuncture Attenuates CFA-Induced Inflammatory Pain by Regulating CaMKII.
    Gu Y; Chen S; Mo Y; Tu Y; Chen N; Zhao X; Li S; Yu Q; Dai Q; Wang J
    Neural Plast; 2020; 2020():8861994. PubMed ID: 33488694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Dopaminergic Receptors Within the Ventral Tegmental Area in Antinociception Induced by Chemical Stimulation of the Lateral Hypothalamus in an Animal Model of Orofacial Pain.
    Matini T; Haghparast A; Rezaee L; Salehi S; Tehranchi A; Haghparast A
    J Pain Res; 2020; 13():1449-1460. PubMed ID: 32606911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lateral Hypothalamus: An Uncharted Territory for Processing Peripheral Neurogenic Inflammation.
    Fakhoury M; Salman I; Najjar W; Merhej G; Lawand N
    Front Neurosci; 2020; 14():101. PubMed ID: 32116534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mesolimbic reward system via laterodorsal tegmental nucleus and hypothalamus in exercise-induced hypoalgesia.
    Kami K; Tajima F; Senba E
    Sci Rep; 2018 Aug; 8(1):11540. PubMed ID: 30069057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.